This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $300

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Dr. Tsubasa Aoki, PhD
Researcher at Ajinomoto Co.
Speaker

Profile

As a researcher at Ajinomoto Co., Inc., Dr. Tsubasa Aoki has been dedicated to antibody engineering, aiming to develop novel drug modalities. His work includes the development of antibody-oligonucleotide conjugates and antibody-protein conjugates. Dr. Aoki earned his Ph.D. in Engineering from the University of Tokyo, Japan, in 2023. His doctoral research focused on supramolecular chemistry and material science, particularly the chiroptical properties of self-assembly systems.

Agenda Sessions

  • Pioneering the Development of Highly Stable Site-Specific Antibody-Oligonucleotide Conjugates (AOC) Using Fc-Targeting Reagents

    8:45am